Mercury Laboratories Ltd.
| BSE: 538964 | Sector: Health care |
| NSE: N.A. | ISIN Code: INE947G01011 |
| BSE 00:00 | 25 Feb | 681.15 |
0 (0.00%) |
OPEN
692.00 |
HIGH
711.00 |
LOW
665.20 |
| NSE 05:30 | 01 Jan | Mercury Laboratories Ltd |
| OPEN | 692.00 |
| PREVIOUS CLOSE | 681.15 |
| VOLUME | 146 |
| 52-Week high | 768.00 |
| 52-Week low | 267.00 |
| P/E | 19.02 |
| Mkt Cap.(Rs cr) | 82 |
| Buy Price | 666.00 |
| Buy Qty | 1.00 |
| Sell Price | 696.70 |
| Sell Qty | 5.00 |
Mercury Laboratories Ltd. (MERCURYLABS) - Net Sales
Market Cap
| COMPANY | LATEST(Rs) | CHG | CHG(%) | Net Sales (Rs crore) |
| Aurobindo Pharma | 865.45 | 2.30 | 0.27 | 13266.48 |
| Cipla | 814.15 | 5.05 | 0.62 | 12659.15 |
| Sun Pharma.Inds. | 616.95 | 7.25 | 1.19 | 12531.93 |
| Dr Reddy's Labs | 4520.30 | 41.05 | 0.92 | 11850.40 |
| Lupin | 1051.95 | 28.50 | 2.78 | 11025.66 |
| Apollo Hospitals | 3154.25 | 63.15 | 2.04 | 9794.50 |
| Glenmark Pharma. | 472.75 | 0.20 | 0.04 | 6712.63 |
| Alkem Lab | 2774.00 | 37.35 | 1.36 | 6677.08 |
| Cadila Health. | 441.15 | 3.35 | 0.77 | 6347.40 |
| Torrent Pharma. | 2468.40 | 3.60 | 0.15 | 6168.44 |
| Divi's Lab. | 3468.00 | 29.00 | 0.84 | 5310.57 |
| Ipca Labs. | 1851.40 | -14.10 | -0.76 | 4337.82 |
| Piramal Enterp. | 1900.20 | -50.20 | -2.57 | 4219.19 |
| Alembic Pharma | 913.65 | 15.85 | 1.77 | 4132.55 |
| Abbott India | 14258.50 | -89.95 | -0.63 | 4093.14 |
| Glaxosmi. Pharma | 1465.00 | -7.10 | -0.48 | 3224.68 |
| Jubilant Pharmo | 751.15 | -6.80 | -0.90 | 3139.90 |
| Sanofi India | 8125.90 | -28.75 | -0.35 | 3070.60 |
| Laurus Labs | 352.55 | -4.80 | -1.34 | 2797.34 |
| Gland Pharma | 2424.55 | 12.85 | 0.53 | 2633.24 |
Quick Links for Mercury Laboratories:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
